News & Press

Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II

Moebius Medical Announces FDA Clearance of IND Application for Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain

Moebius Announces Acceptance of Abstract to OARSI 2020 Congress Showing MM-II’s Ability to Coat Cartilage in-vivo and Reduce Friction and Wear in ex-vivo Cartilage Models.

Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis

Moebius selected to present at Tech Tour Healthcare Summit

Moebius shares its experience of negotiating with TTOs at MIXiii BioMed 2017 Conference

Moebius invited to participate in Startup Nation Conference – Miami

Moebius presents poster at OARSI highlighting results of first prospective randomized double-blinded study

Highlights of Moebius’s RCT presented at American College of Rheumatology Meeting

Poster presentation at AAOS demonstrating Safety and Efficacy of Liposome Intraarticular Injection in Moderate Knee Osteoarthritis